| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 04/14/2011 | US20110086799 GnRH II Analogs and Uses Thereof in the Immune System |
| 04/14/2011 | US20110086795 Small peptide modulators of potassium channel trafficking |
| 04/14/2011 | US20110086416 Immunotoxin fusion proteins and means for expression thereof |
| 04/14/2011 | US20110086055 Her2 peptides |
| 04/14/2011 | US20110086049 Receptor Modulators |
| 04/14/2011 | US20110086028 Prevention of hiv infection |
| 04/14/2011 | US20110086015 Zinc finger nuclease for the cftr gene and methods of use thereof |
| 04/14/2011 | US20110085989 Novel antimicrobial peptides |
| 04/13/2011 | EP2307446A1 Nonimmunosuppressive cyclosporine analogue molecules |
| 04/13/2011 | EP2307445A1 Process for preparing caspofungin and intermediates thereof |
| 04/13/2011 | EP1425296B1 Organic compounds with biological activity as thrombin inhibitors and use thereof |
| 04/13/2011 | CN102015632A Synthesis of a PEG-6 moiety from commercial low-cost chemicals |
| 04/13/2011 | CN102012431A CCP (Cyclic Citrullinated Peptide) used for detecting the immune antibody of rheumatoid arthritis with dot immuno-gold filtration assay |
| 04/13/2011 | CN102010884A Antibacterial active matter as well as preparation method and application thereof |
| 04/13/2011 | CN102010461A Alpha spiral cation polypeptide molecule and preparation method and application thereof |
| 04/13/2011 | CN101333246B Neutral B cell antigen epitope polypeptide of encephalitis b virus E protein and uses thereof |
| 04/13/2011 | CN101048170B Analgesic peptide like compounds stemed from rattlesnake crotalus durissus terrificus snake wenom, their application, compositions, preparation and purification method |
| 04/12/2011 | US7923543 Nucleic acid and corresponding protein entitled 162P1E6 useful in treatment and detection of cancer |
| 04/12/2011 | US7923534 Isolated tumor rejection antigen precursor proteins MAGE-2 and MAGE-3 |
| 04/12/2011 | US7923221 Methods of making antibody heavy and light chains having specificity for a desired antigen |
| 04/12/2011 | CA2396542C Composition promoting lacrimal secretion |
| 04/12/2011 | CA2361725C Selection of proteins using rna-protein fusions |
| 04/12/2011 | CA2050318C Endothelial cell growth factor, methods of isolation and expression |
| 04/07/2011 | WO2011040823A1 Synthetic myostatin peptide antagonists |
| 04/07/2011 | WO2011040564A1 Ophthalmic agent comprising specific peptide compound as active ingredient |
| 04/07/2011 | WO2011040500A1 Peptide inhibiting differentiation of hematopoietic stem cells or hematopoietic precursor cells and use of same |
| 04/07/2011 | WO2011003935A4 Parathyroid hormone related protein antagonists |
| 04/07/2011 | WO2010132869A3 Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use |
| 04/07/2011 | WO2010132609A3 Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory |
| 04/07/2011 | US20110082280 Methods Of Coupling Multidentate AZA Ligands To Targeting Molecules |
| 04/07/2011 | US20110082094 Mammalian Cytokine-Like Polypeptide-10 |
| 04/07/2011 | US20110082091 Method for Preclinical Testing of Immunomodulatory Drugs |
| 04/07/2011 | US20110082089 Biomarkers for monitoring or predicting the treatment of cancer |
| 04/07/2011 | US20110082082 Skin wound healing compositions and methods of use thereof |
| 04/07/2011 | US20110082080 Compositions and methods of using the human proislet peptide receptor |
| 04/07/2011 | US20110081730 Activating mutations of platelet derived growth factor receptor alpha (pdgfra) as diagnostic markers and therapeutic target |
| 04/07/2011 | US20110081660 Method for Detecting Misfolded Proteins and Prions |
| 04/07/2011 | US20110081371 Angiotensin peptide-carrier conjugates and uses thereof |
| 04/07/2011 | US20110081293 Methods and compositions related to clot-binding lipid compounds |
| 04/07/2011 | DE102009039705A1 Peptide des CENP-A und ihre Verwendung Peptides of the CENP-A and their use |
| 04/07/2011 | CA2776529A1 Synthetic myostatin peptide antagonists |
| 04/07/2011 | CA2775720A1 Peptides for inducing heterosubtypic influenza t cell responses |
| 04/06/2011 | EP2303916A1 Method for producing intermediates for the production of novel macrocycles that are inhibitors of the proteasomic degradation of p27, such as argyrin and derivatives thereof, and uses of said macrocycles |
| 04/06/2011 | EP2303915A2 Pseudacyclin and method of indication of a fungus pseudallescheria boydii |
| 04/06/2011 | EP2303914A1 Peptide manufacturing process |
| 04/06/2011 | EP2303913A2 Crkl targeting peptides |
| 04/06/2011 | EP2303912A1 Cdca1 epitope peptides and vaccines containing the same |
| 04/06/2011 | EP2303911A1 An synthetic peptide containing bone forming peptide 2(bfp 2) for stimulating osteoblast differentiation, and pharmaceutical composition comprising the synthetic peptide |
| 04/06/2011 | EP2303910A1 Multi-leu peptides and analogues thereof as selective pace4 inhibitors and effective antiproliferative agents |
| 04/06/2011 | EP2303909A1 Iqgap3 epitope peptides and vaccines containing the same |
| 04/06/2011 | EP2303908A2 Fluorescent cyclic peptides, methods for the preparation thereof, and use of said peptides for measuring the enzymatic activity of a protease enzyme |
| 04/06/2011 | EP1370277B1 Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis |
| 04/06/2011 | CN1910284B Epitope/peptide recognized by HLA-A2402-restricted Ep-CAM-specific CTL and use of the same |
| 04/06/2011 | CN1883710B Chemical modification method of antineoplastic oligopeptide and application thereof |
| 04/06/2011 | CN1658893B G-type peptides to ameliorate atherosclerosis |
| 04/06/2011 | CN102007217A Enzymatic conjugation of bioactive moieties |
| 04/06/2011 | CN102007140A Biologically active peptides |
| 04/06/2011 | CN102004154A Composition for detecting immune antibodies of rheumatoid arthritis by dot immunogold filtration assay |
| 04/06/2011 | CN102002102A Body weight modulators, corresponding nucleic acids and proteins, and their use for diagnosis and therapy |
| 04/06/2011 | CN102002096A Amphipathic compound using somatostatin analogue as target radical and pharmaceutics application thereof |
| 04/06/2011 | CN102002095A Microwave irradiation solid phase synthesis of balsam pear hypoglycemic MC-JJ0108 polypeptide analogue and application thereof |
| 04/06/2011 | CN101497652B Peptide for inhibiting solid tumor and leukaemia cancer cell growth and use thereof |
| 04/06/2011 | CN101270151B Peptide medicaments for accelerating medulla hematopoiesis cell proliferation |
| 04/05/2011 | US7919582 Neuregulin-β isoform |
| 04/05/2011 | US7919579 Imaging and therapeutic targeting of prostate and bladder tissues |
| 04/05/2011 | US7919466 Lymphatic zip codes in tumors and pre-malignant lesions |
| 04/05/2011 | US7919459 Cardiovascular disorders; antidiabetic agents; respiratory system disorders; antagonist of protein g receptor |
| 04/05/2011 | US7919263 Organic material-immobiling structure and method for production of the same, and peptide and DNA therefor |
| 04/05/2011 | US7919076 PH-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 04/05/2011 | CA2466170C Hexa-, hepta-, and octapeptides having antiangiogenic activity |
| 03/31/2011 | WO2011038149A2 Methods of treating inflammation |
| 03/31/2011 | WO2011038142A2 Bladder cancer specific ligand peptides |
| 03/31/2011 | WO2011038066A2 Novel npr-b agonists |
| 03/31/2011 | WO2011038061A2 Novel npr-b agonists |
| 03/31/2011 | WO2011038049A1 Peptidomimetic macrocycles |
| 03/31/2011 | WO2011037859A2 Identification of antigenic peptides from multiple myeloma cells |
| 03/31/2011 | WO2011036445A2 Polypeptides and uses thereof |
| 03/31/2011 | WO2011036444A1 Heparin cofactor ii fragments with anti-inflammatory and anti-coagulant activity |
| 03/31/2011 | WO2011035492A1 High yield antibiotics producing fungus strain, preparation method and use thereof |
| 03/31/2011 | WO2010129890A3 Compounds and methods for inhibiting platelet aggregation |
| 03/31/2011 | US20110077381 Novel npr-b agonists |
| 03/31/2011 | US20110077205 Production and Use of Antitumoral Cyclodepsipeptides |
| 03/31/2011 | US20110077192 Novel Antibacterial Peptides |
| 03/31/2011 | US20110077191 Novel inhibitors of mammalian tight junction opening |
| 03/31/2011 | US20110076723 Antibody-peptide fused synergibody |
| 03/31/2011 | US20110076693 Method for detection and quantification of plk1 expression and activity |
| 03/31/2011 | US20110076347 Molecules Interfering with Binding of Calbindin to Inositol Monophosphatase for the Treatment of Mood Disorders |
| 03/31/2011 | US20110076342 Cancer peptide therapeutics |
| 03/31/2011 | US20110076297 Peptides for Inducing Heterosubtypic Influenza T Cell Responses |
| 03/31/2011 | US20110076264 Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such |
| 03/31/2011 | US20110076234 Peptides comprising an isodgr motif |
| 03/31/2011 | US20110076233 Delivery System for Cytotoxic Drugs by Bispecific Antibody Pretargeting |
| 03/31/2011 | CA2775465A1 High-yield antibiotics producing fungus strain, preparation method and use thereof |
| 03/31/2011 | CA2774973A1 Peptidomimetic macrocycles |
| 03/31/2011 | CA2774946A1 Identification of antigenic peptides from multiple myeloma cells |
| 03/31/2011 | CA2774296A1 Polypeptides and uses thereof |
| 03/31/2011 | CA2774288A1 Heparin cofactor ii fragments with anti-inflammatory and anti-coagulant activity |
| 03/31/2011 | CA2773978A1 Methods of treating inflammation |
| 03/31/2011 | CA2773949A1 Novel npr-b agonists |
| 03/30/2011 | EP2301953A1 Binding molecules for human factor VIII and factor VIII-like proteins |